drugset / Trial / NCT03680911

NAC for Head Trauma-induced Anosmia

NCT03680911

Phase 3 Terminated 7 enrolled University of Miami
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare administration of N-Acetyl Cysteine (NAC) versus placebo for the treatment of olfactory loss due to head injury. The hypothesis is that treatment with NAC acutely after head injury will result in improved olfactory function

Timeline

Start
2018-10-12
Primary completion
2020-01-07
Completion
2020-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 2 g Oral